Skip to main content
. 2021 Jan 7;31:100683. doi: 10.1016/j.eclinm.2020.100683

Table 4.

Anxiety (GAD-7), depression (PHQ-9), quality of life (SF-36) and symptom (dyspnoea, fatigue) burden in patients and controls.

COVID-19 CONTROL p-value
GAD-7
Score 2·0 (0·0 - 7·5) 0·5 (0·0 - 4·3) 0·066+
0 – 4 (Minimal) 35/57 (61·4%) 23/30 (76·7%)
5 – 9 (Mild) 14/57 (24·6%) 6/30 (20·0%)
10 – 14 (Moderate) 3/57 (5·3%) 1/30 (3·3%)
≥15 (Severe) 5/57 (8·8%) 0/30 (0·0%)
Moderate or worse anxiety
≥10 (Moderate or more) 8/57 (14%) 1/30 (3.3%) 0.16ᵋ
PHQ-9
Score 3·0 (1·0 - 7·5) 1·5 (0·0 - 5·0) 0·009+
0 - 4 (Minimal) 33/57 (57·9%) 21/30 (70·0%)
5 - 9 (Mild)– 13/57 (22·8%) 8/30 (26·7%)
10 - 14 (Moderate)– 7/57 (12·3%) 1/30 (3·3%)
≥15 (Moderately severe or severe) 4/57 (7·0%) 0/30 (0·0%)
Moderate or worse mood symptoms
≥10 (Moderate or more) 11/57 (19·3%) 1/30 (3·3%) 0.051ᵋ
SF-36 Domains
Physical Functioning 65·0 (45·0 - 90·0) 92·5 (83·8 - 100·0) <0·0001⁺
Role Limitations Due to Physical Health 25·0 (0·0 - 75·0) 100·0 (100·0 - 100·0) <0·0001⁺
Role Limitations Due to Emotional Health 33·3 (0·0 - 100·0) 100·0 (100·0 - 100·0) <0·0001⁺
Energy 45·0 (25·0 - 70·0) 65·0 (55·0 - 80·0) <0·0001⁺
Emotional Well-Being 76·0 (62·0 - 88·0) 84·0 (72·0 - 92·0) 0·044⁺
Social Functioning 50·0 (37·5 - 87·5) 100·0 (62·5 - 100·0) 0·0002⁺
Pain 67·5 (35·0 - 90·0) 85·0 (67·5 - 100·0) 0·003⁺
General Health 68·8 (43·8 - 81·3) 75·0 (60·9 - 87·5) 0·022⁺
Dyspnoea - 12 symptom score
Median (IQR) 4·0 (1·0 - 11·0) 0·0 (0 -1·5) <0·0001+
Fatigue Severity Scale
Median (IQR) 34 (18 - 49) 17 (11 - 24) 0·001+
/≥4 30/55 (54·5%) 5/29 (17·2%) 0·010ᵋ
Medical Research Council Dyspnoea Scale
MRC grade 2 - 5 36/56 (64·3%) 3/29 (10·3%) <0·0001ᵋ

Data are median (IQR) and n/N (%), where N is the total number of participants with available data. p-values from Mann-Whitney U test (+) or Fisher's exact test (ᵋ). GAD-7 = Generalised anxiety disorder-7 assessment. PHQ-9 = Patient health questionnaire-9 assessment. SF-36 = Short form 36. MRC = Medical Research Council Scale. Control subjects were matched for co-morbidities as closely as possible.